It is a highly heterogeneous disease classified into four major molecular subtypes: triple-negative breast cancer (TNBC), human epidermal growth factor receptor 2 (HER2)-positive, Luminal A, and Luminal B, as defined by the 13th St. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.